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Abstract  
Background: Medicine is becoming an increasingly data-centered discipline and, beyond 
classical statistical approaches, Artificial Intelligence (AI) and, more in particular, Machine 
Learning (ML) are attracting much interest for the analysis of medical data. It has been argued 
that AI is experiencing a fast process of commodification. This characterization correctly reflects 
the current process of industrialization of AI and its reach into society. Therefore, societal issues 
related to the use of AI and ML should not be ignored any longer and certainly not in the medical 
domain. 
These societal issues may take many forms but they all entail the design of models from a 
human-centered perspective, incorporating human-relevant requirements and constraints. In 
this brief paper, we discuss a number of specific issues affecting the use of AI and ML in medicine 
such as fairness, privacy and anonymity, explainability and interpretability, but also some 
broader societal issues such as ethics and legislation. We reckon that all of these are relevant 
aspects to consider in order to achieve the objective of fostering acceptance of AI and ML-based 
technologies, as well as to comply with an evolving legislation concerning the impact of digital 
technologies on ethically and privacy sensitive matters. Our specific goal here is to reflect on 
how all these topics affect medical applications of AI and ML. 
This paper includes some of the contents of the 2nd Meeting of Science and Dialysis: Artificial 
Intelligence, organized in the Bellvitge University Hospital, Barcelona, Spain. 
Summary and Key Messages: 
AI and ML are attracting much interest from the medical community as key approaches for 
knowledge extraction from data. 
These approaches are increasingly colonizing ambits of social impact such as medicine and 
healthcare. 
Issues of social relevance with an impact on medicine and healthcare include (although are not 
limited to) fairness, explainability, privacy, ethics and legislation. 
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Introduction 
Medicine, as part of a phenomenon that affects all fields of Life Sciences, is becoming an 
increasingly data-centered discipline [1]. Data analysis in medicine has for long been the 
territory of statisticians, but medical data are reaching beyond the merely quantitative to take 
more complex forms, such as, for instance, textual information in Electronic Health Records 
(EHR), images in many modalities, on their own or mixed with other types of signal, or graphs 
describing biochemical pathways or biomarker interactions [2]. This data complexity is behind 
the evolution from classical multivariate data analysis towards the nascent field of data science 
[3], which, from the point of view of medicine, embraces a new reality that includes 
interconnected wearable devices and sensors. 
Beyond the more classical statistical approaches, Artificial Intelligence (AI) and, more in 
particular, Machine Learning (ML) are attracting much interest for the analysis of medical data, 
even if arguably with relatively low impact yet on clinical practice [4]. It has been acknowledged 
that AI is experiencing a fast process of commodification (not that this is an entirely new 
concern, as it was already matter of academic discussion almost thirty years ago [5]). This 
characterization is mostly of interest to big IT companies, but correctly reflects the current 
process of industrialization of AI, where the academic and industrial limits of research are 
increasingly blurred, with the main experts in AI and ML on the payroll of private companies. In 
any case, this means that AI systems and products are reaching the society at large and, 
therefore, that societal issues related to the use of AI in general and ML in particular should not 
be ignored any longer and certainly not in the medicine and healthcare domains. 
These societal issues may take many forms but, more often than not, they entail the design of 
models from a human-centered perspective, that is, models that incorporate human-relevant 
requirements and constraints. This is certainly an only partially technical matter. 
In this brief paper, we cover, in a non-exhaustive manner, a number of specific societal issues 
affecting the development of AI and ML methods such as fairness, privacy and anonymity, and 
explainability and interpretability, but also some broader societal issues such as ethics and 
legislation. Not that these issues should be considered independently; on the contrary, they 
often overlap in an intricate manner. Let us summarily list them here: 
Legislation: The industrialization of AI exposes it to legislation regulating the social domain 
where it is meant to operate. In some cases, this overlaps issues of privacy and anonymity, such 
as in AI algorithms used for automated face recognition in public domains. It may also involve 
more general contexts, such as AI-based autonomous driving or defence weapons. Legislation is 
also involved in medicine and healthcare practice and, therefore, we need to ensure that AI and 
ML technologies comply with current legislation.    
Explainability and interpretability: ML and AI algorithms are often characterized as black boxes, 
that is, methods that generate data models that are difficult (if not impossible) to interpret 
because the functional form relating the available data (input) to a given outcome (the output) 
is far too complex. This problem has been exacerbated by the intensity of current interest in 
Deep Learning (DL) methods. Only interpretable models can be explained, and explainability is 
paramount when decision making in medicine (diagnosis, prognosis, etc.) must be conveyed to 
humans. 
Privacy and anonymity: Privacy-preserving ML-based data analysis must deal with the 
potentially contradictory problem of keeping personal information private while aiming to 
model it, often to make inferences that will affect a given population. Data anonymity obviously 
refers to the impossibility of linking personal data with information about the individual that is 
not meant to be revealed. These are key problems and concerns in the medical and healthcare 
domains, mainly in the interaction between the public and private sectors. 
Ethics and fairness:  Biological intelligence is multi-faceted and responds to the environmental 
pressures of human societies. Ethics are one of those facets, for which AI is still fairly 
unprepared. Interestingly, this topic has become central to AI discussion in recent years. 
Needless to say, ethics are also a core concern in medicine and healthcare. Such convergence of 
interests makes it important to create a clear roadmap for the ethical use of AI and ML in 
medicine. The application of ML and AI in areas of social relevance must also aspire to be fair. 
How to imbue ML algorithms, which are fairness-agnostic, with fairness requirements? How do 
we avoid gender or ethnicity, for instance, unfairly influencing the outcome of a learning 
algorithm? In the medical domain and in healthcare in particular, where sensible information 
about the individual may be readily available, how do we ensure that AI and ML-based decision 
support tools are not affected by such bias?  
We reckon that all of these are relevant aspects to consider in order to achieve the objective of 
fostering acceptance of AI and ML-based technologies in the medical and healthcare domains, 
as well as to comply with an evolving legislation concerning the impact of digital technologies 
on ethically and privacy sensitive matters. Our specific goal here is to reflect on how all these 
topics affect medical applications of AI and ML. 
This paper reflects some topics addressed in the 2nd Meeting of Science and Dialysis: Artificial 
Intelligence, organized in the Bellvitge University Hospital, Barcelona, in the Catalonia region of 
Spain. 
 
Societal issues of AI and ML application 
Legislation 
Human societies are regulated by bodies of legislation. While remaining within the academic 
realm, AI and ML developments have stayed fairly oblivious to legal concerns, but the moment 
these technologies start occupying the social space at large, their impact on people is likely to 
hit a few legal walls. One widely discussed case is the use of AI as the basis for autonomous 
driving vehicles. When a human is in charge of any decision making at the wheel of a vehicle, 
legal responsibilities are quite clearly drawn. The quick industrial development of semi-
autonomous vehicles, leading towards the objective of fully autonomous driving, has stretched 
the seams of current legislation, though. 
Again, any application of AI and ML in actual medical practice is bound to generate discussion 
about its legal boundaries and implications. A pertinent example is the recent (May 2018) 
implementation of the European Union directive for General Data Protection Regulation (GDPR). 
This directive mandates a right to explanation of all decisions made by “automated or artificially 
intelligent algorithmic systems” [6]. According to Article 13 of the directive, the right to 
explanation implies that the “data controller” is legally bound to provide requesting citizens with 
“meaningful information about the logic involved, as well as the significance and the envisaged 
consequences of such processing [automated decision making, as described in its Article 22] for 
the data subject". AI and ML maybe the tools used to provide such automated decision making 
and, therefore, it places these technologies in a legal spotlight. Some guidelines for GDPR-
compliant ML development have recently been provided in [7]. 
The implications of GDPR for the use of AI and ML in medicine and healthcare are not too difficult 
to appreciate. Any AI or ML based medical decision support system (MDSS) whose purpose is to 
assist the medical experts in their decision making will be explicitly providing a (semi)automated 
decision on an individual (for instance, diagnosis, prognosis or recommendations of treatment 
concerning individual patients, perhaps even in life-threatening conditions). The data controller 
in this case will be the medical expert (from nurses to specialists [8]) and the institution this 
expert belongs to. 
Note that this piece of legislation (of compulsory application in all countries belonging to the 
European Union) requires something very specific from the AI and ML technologies (or, more 
accurately, from the people designing, implementing and using them): interpretable and 
explainable models, as we discuss in the next section. A medical expert or any healthcare system 
employee using these technologies must be able to interpret how they reached specific 
decisions (say, why an ML model diagnosed a brain tumour as a metastasis and not a high grade 
glioma) and must be able to explain those decisions to any human affected by them. In the 
implementation of the artificial kidney as one of the most promising technologies in nephrology, 
we should be concerned, for instance, about the possibility of an opaque AI or ML-based alarm 
system not being able to explain the basis for a false alarm that might endanger the life of the 
dialysis patient. 
At a higher level, and on the basis of legal safeguards such as the GDPR, a healthcare system 
might decide not to implement an opaque MDSS in clinical practice despite its perceived 
effectiveness, only to avoid the prospect of unsustainable litigation costs caused by the false 
positive and negative cases or the incorrect estimations and predictions churned by these 
automated systems. 
On the light of this discussion, we recommend that medical experts and healthcare practitioners 
should keep in mind the need to balance the effectiveness of AI and ML-based technologies and 
their adherence to current legislation. Beyond GDPR and its relation to interpretability, this issue 
overlaps some of the others we discuss in the following sections, such as ethics, fairness, and 
privacy and anonymity. 
 
Interpretability and explainability 
Biological brains have not necessarily evolved means to explain themselves. Arguably, this has 
only happened in species with social behavior (although it could also be argued that social 
behavior can only happen in species whose brains are capable of explaining themselves through 
some form of communication). In the human species, natural language performs that 
communicative or explanatory function. 
AI was originally conceived as an attempt to reproduce aspects of biological intelligence, but 
self-explanatory capabilities were never a key aspect to consider. If the biological brain was 
meant to be understood as a form of information processing system, so was AI, and the idea of 
social AI is relatively new, for instance in the form of intelligent agents and multi-agent systems 
[9]. Only recently the interpretability and explainability of AI and ML systems has come to the 
forefront of research in the field [10]. One key reason for that is the breakthrough created by DL 
technologies. DL is an augmented version of traditional ANNs. The latter were long ago maligned 
as black box opaque models. DL models risk being considered augmented black boxes. 
Interpretability in this context can be seen as a human-computer interaction problem. We 
humans must be able to understand and interpret the outcome of an AI or ML model. That is, 
we need to ensure that even a very complex model can be explained (usually to other humans). 
A human brain, colossally more complex, has developed natural language to convey some level 
of explanation of its inner workings. Similar attempts with AI and ML are still very limited. 
Despite recent and thorough attempts to address the issue of how to characterize 
interpretability in ML [11], such attempts only highlight the tremendous difficulty involved in 
the scientific pursue of truly interpretable ML models. 
In the medical domain, AI and ML models are often part of MDSS. Their potential and the 
possible barriers to their adoption have been investigated in the last decade [12]. The paradox 
is that these methods, despite their advantages, are far from universal acceptance in medical 
practice. Arguably [13], one of the reasons is precisely (lack of) interpretability, expressed as 
“the need to open the machine learning black box". As already mentioned, DL-based 
technologies can worsen the problem, despite having already found their way into biomedicine 
and health care [14,15]. In medicine, this has clear implications: if an ML-based MDSS makes 
decisions that cannot be comprehensibly explained, the medical expert can be put in the 
uncomfortable position of having to vouch for the system’s trustworthiness, transferring the 
trust on a decision that she or he cannot explain to either the patient or to other medical experts. 
This does not mean to say that efforts have not been made to imbue MDSS with knowledge 
representations that are comprehensible to humans. Examples include rule-based 
representations, usually compatible with medical reasoning [16]; and nomograms, commonly 
used by clinicians for visualizing the relative weights of symptoms on a diagnosis or a prognosis 
[17].  
AI and ML-based systems may have quantifiable goals and still be useless unless they conform 
to clinical guidelines. Note that computer-based systems such as MDSS are often seen by 
clinicians as an extra burden in their day-to-day practice [18]. The problem may appear when 
the MDSS conflicts with guidelines of medical practice [19], something bound to happen unless 
those guidelines are somehow fed as prior knowledge to the intelligent systems. In this scenario, 
interpretability might be seen as an opportunity to make model performance and compliance 
with guidelines compatible goals. 
The role of ML in healthcare has been described as acting “as a tool to aid and refine specific 
tasks performed by human professionals" [20]. Note that this means that interpretability should 
not be considered here a fully technical issue dissociated from the cognitive abilities of the 
human interpreter. As acknowledged in [12] when discussing the weak levels of adoption of 
MDSS at the point of care, researchers often sidestep practical questions such as whether 
adequate “explanations [are] given for the system's diagnosis"; “the form of explanation [is] 
satisfactory for the physicians using the system"; or “how intuitive is its use". 
An effort should be made to integrate medical expert knowledge into the AI and ML models, or 
use prior expert knowledge in formal frameworks for machine-human interaction in the pursuit 
of interpretability and explainability. The data analyst must play a proactive role in seeking 
medical expert verification. In return, the medical expert should ensure that the analysis 
outcomes are interpretable and usable in medical practice. 
Privacy and anonymity 
Technological advances and the widespread adoption of networked computing and 
telecommunication systems are flooding our societies (and mostly governments and technology 
providers) with data. The physical society bonds are being swiftly amplified by our use of virtual 
social networks. In this scenario, data privacy and anonymity have become main social concerns 
and have triggered legal initiatives such as the European GDPR discussed in previous sections. 
Needless to say, privacy and anonymity have been a core concern for healthcare systems for far 
longer than for society at large. The current adoption of EHRs in medical practice enhances this 
issue, as sensitive patient data are uploaded in digital form to networked systems with varying 
levels of security systems in place. An interesting review on security and privacy in EHRs can be 
found in [21]. The strong links between privacy and anonymity, on one side, and legislation on 
the other are clearly described in this study, although it is also acknowledged that “there has 
been very little activity in policy development involving the numerous significant privacy issues 
raised by a shift from a largely disconnected, paper-based health record system to one that is 
integrated and electronic”. 
This is not an issue ignored by the AI and ML communities. As early as 2002, data confidentiality 
and anonymity in data mining medical applications were already being discussed in journals of 
these fields [22], highlighting the responsibilities of data miners to human subjects. Privacy-
preserving models and algorithms have been discussed in some detail [23]. A commonplace 
situation for data analysts in clinical environments is the need to analyze data that are 
distributed among multiple clinical parties. These parties (e.g, hospitals) may have privacy 
protocols in place that prevent merging data from different origins into centralized locations (in 
other words, prevent data “leaving” a given hospital). The AI and ML communities have already 
worked on producing decentralized analytical solutions to bypass this bottleneck [24]. 
There is a new and disruptive element of the privacy and anonymity discussion in AI and ML 
applications in medicine that must be considered. The en masse landing of big IT corporations 
in the medical field, many of them proposing or integrating AI elements (some examples would 
be Microsoft’s Hanover project, IBM’s Watson Oncology, or Google’s DeepMind), together with 
a myriad of AI-based medically-oriented startups1.  The involvement of IT companies in health 
provision raises the bar for privacy and anonymity issues that were already on the table due to 
the pressure of insurance companies, especially in the most liberalized national health systems. 
An illustrative example of the complexities and potential drawbacks of this involvement can be 
found in Nature journal’s report [25] of U.K. Information Commissioner’s Office declaration that 
the operator of three London-based hospitals “had broken civil law when it gave health data to 
Google’s London-based subsidiary DeepMind”. These data were meant to be the basis for 
models to test results for signs of acute kidney injuries, but privacy and identifiability protocols 
were breached in a large scale transference of patients’ data from the hospitals to the private 
company. According to the Royal Statistical Society’s executive director, three lessons are to be 
extracted from this particular case of application to the medical domain: 1) due to society’s 
increasing data trust deficit, data transference transparency and openness should be 
guaranteed; 2) data transference should be proportional to the medical task at hand (in this 
case, the development of models for detection of signs of acute kidney injury): and 3) 
governance (not just legislation) mechanisms of control of data handling, management and use 
                                                          
1 http://medicalfuturist.com/top-artificial-intelligence-companies-in-healthcare (January 2017, last 
accessed June 2018) 
should be strengthened or created when necessary. He also makes a key statement when saying 
that “innovations such as artificial intelligence, machine learning […] offer great opportunities, 
but will falter without a public consensus around the role of data”.   
Ethics and fairness 
The time-honoured ultimate aspiration of AI is to replicate biological intelligence in silico. 
Biological intelligence, though, is the product of evolution and, as such, is multi-faceted and at 
least to some extent the product of environmental pressures of human societies. Ethics, as a 
compass for human decision making, are one of those facets and could be argued to provide the 
foundations for the legislative regulation of societies, whose importance for medical 
applications of AI and ML has already been discussed in this paper.  
The truth though is that the AI and ML fields are still fairly unprepared to address this pressing 
matter [26]. Interestingly, this topic has become central to AI discussion only in recent years, 
once it has also become a central topic in global research agendas [27]. In what sense ethics 
might be part of the AI and ML equation and in what sense do we want these technologies be 
imbued with ethical considerations, beyond the overlap with bodies of regulation and 
legislation? Let us provide an illustrative example: the ongoing debate on the use of AI as part 
of autonomous weapons systems in defence and warfare. Unmanned autonomous vehicles, at 
least partially driven by AI, are being used for targeted bombing in areas of conflict. The ethical 
issues involved in human decisions concerning the choice of human targets in war periods are 
quite clearly delineated by international conventions, but, who bears ethical responsibility in the 
case of targets at least partially chosen by AI-driven machines? This type of problem currently 
drives not-for-profit organization campaigns such as those undertaken by Article 362  “to stop 
killer robots”3. 
Needless to say, ethics are also a core concern in medicine and healthcare that has attracted 
much academic discussion [28]. Can AI and ML-supported tools address the basic biomedical 
ethics principles of respect for autonomy, nonmaleficence, beneficence and justice? Should 
they, or should this be left to the medical practitioners? Medical practitioners, though, do not 
usually develop the AI and ML tools for medical application. Should they at least ensure that AI 
and ML developers do not transgress these principles in the design of such tools? According to 
[29], it is humans and not systems who can identify ethical issues and, therefore, it is important 
to consider “the motivations and ethical dilemmas of researchers, developers and medical users 
of ML methods in medical applications”. 
Such convergence of interests makes it important, in any case, to create a clear roadmap for the 
ethical use of AI and ML in medicine that involves players both from the fields of medicine and 
AI. 
The concept of fairness may be considered as subjective as the concept of ethics and, perhaps, 
more vaguely defined. If distinguishing what is fair and what is not in a human society is difficult 
and often controversial, trying to embed the concept of fairness in AI-based decision making 
might be seen as a hopeless endeavour. Nevertheless, the use of ML and AI in socially relevant 
areas should at least aspire to be fair. As stated in [30] “real-world fairness challenges in ML are 
not abstract, […] but are institutionally and contextually grounded”. 
                                                          
2 http://www.article36.org 
3 https://www.stopkillerrobots.org 
Let us illustrate this with an example: gender bias can be added to an ML model by just biasing 
the choice with which the data used to train the model are selected. Caliskan and co-workers 
have recently shown that semantics derived automatically using ML from language corpora will 
incorporate human-like stereotyped biases [31]. As noted in [30], lack of fairness may 
sometimes be the inadvertent result of organisations not holding data on sensitive attributes 
such as gender, ethnicity, sexuality or disability due to legal, institutional or commercial reasons. 
Without such data, indirect discrimination-by-proxy risks being increased.  
In the medical domain and in healthcare in particular, where sensible information about the 
individual may be readily available, how do we ensure that AI and ML-based decision support 
tools are not affected by such bias? Fairness constraints can be integrated in learning algorithms, 
as shown in [32]. Given that fairness criteria are reasonably clean-cut in the medical context, 
such constraints should be easier to integrate than in other domains. Following [30], fairness 
may be helped by trusting third parties with the selective storage of those data that might be 
necessary for incorporating fairness constraints into model-building in a privacy-preserving 
manner. A recent proposal of a “continuous framework for fairness” [33] seeks to subject 
decision makers to fairness constraints that can be operationalized in an algorithmic (and 
therefore in AI and ML) setting, with such constraints facilitating a trade-off between individual 
and group fairness, a type of trade-off that could have clear implications in medical domains 
from access to drugs and health services to personalized medicine. 
 
Conclusions 
AI and ML have, for decades, been mostly investigated and developed within the academic 
environment, with some inroads into broader social domains. Over the last years, though, these 
fields are experiencing an intense process of industrialization that comes with societal strings 
attached. Many of these should concern medical and healthcare practice and have been brought 
to attention and discussed in this paper. We have considered legislation, ethics and fairness, 
interpretability and explainability and privacy and anonymity, but further issues such as 
robustness and safety, economics and accessibility, or complex data management could have 
also been considered. Our closing remark is a call for the collaboration between the AI-ML and 
medicine-healthcare communities in the pursuit of methods, protocols, guidelines and data 
analysis pipelines that explicitly take into consideration all these societal issues.  
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